Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Vasc Surg. 2022 Dec;76(6):1588-1595.e1. doi: 10.1016/j.jvs.2022.04.057. Epub 2022 Jul 5.
To assess the outcome of ex vivo renal artery repair with orthotopic renal autotransplantation for patients with complex renal artery disease.
The single-center study collected and analyzed the data from patients with complex renal artery disease undergoing ex vivo renal artery repair with orthotopic renal autotransplantation, retrospectively.
A total of 21 complex renal artery lesions from 19 patients were included. The mean blood pressure showed a significant decrease from the preoperative to the postoperative period (P < .05). Renal function kept stable for the perioperative period. No significant serum creatinine and estimated glomerular filtration rate alteration was observed compared with the immediate postoperative period (P = .439 and .904, respectively). The median renal cold ischemia time was 35.5 (76) minutes. Two patients developed perioperative complications, one with acute cholecystitis and one with acute renal failure after graft occlusion in a solitary kidney. During the median follow-up of 48 months, one single bypass graft of a solitary kidney was occluded, and four grafts developed restenosis. The primary and primary-assisted patency rates at the 5-year follow-up were 81.3% and 87.5%, respectively. No deaths were observed in the follow-up period.
Ex vivo renal artery reconstruction with orthotopic renal autotransplantation in patients with complex renal artery disease offers stable control of blood pressure and renal function preservation, and should be considered as a potential alternative for other open surgical procedures.
评估体外肾动脉修复伴同种异体肾自体移植治疗复杂肾动脉疾病患者的结局。
该单中心研究回顾性地收集和分析了 19 例接受体外肾动脉修复伴同种异体肾自体移植的复杂肾动脉疾病患者的数据。
共纳入 19 例患者的 21 处复杂肾动脉病变。与术前相比,平均血压在术后显著下降(P<0.05)。围手术期肾功能保持稳定。与术后即刻相比,无明显血清肌酐和估算肾小球滤过率改变(P=0.439 和 0.904)。肾冷缺血时间中位数为 35.5(76)分钟。2 例患者发生围手术期并发症,1 例并发急性胆囊炎,1 例孤立肾移植后发生急性肾衰竭。在 48 个月的中位随访期间,1 例孤立肾的单支旁路移植血管闭塞,4 支移植血管发生再狭窄。5 年随访时的主要和主要辅助通畅率分别为 81.3%和 87.5%。随访期间无死亡。
体外肾动脉重建伴同种异体肾自体移植治疗复杂肾动脉疾病可稳定控制血压和保护肾功能,应被视为其他开放手术的潜在替代方法。